Spring 2015: Dr. John Crew Radio Interview 3/11/2015 on Health Media Now Radio [MP3]

Newsletter Spring 2014: Saving Lives and Limbs From “Flesh-Eating Disease” [PDF]


U.S. Events

SAWC Spring

4/5/17 - 4/9/17
San Diego, CA


AGH Wound Conference

Pittsburgh, PA


WOCN - Annual Conference

5/20/17 - 5/22/17
Salt Lake City, UT


NASVH Conference

7/24/17 - 7/28-17
Orlando, FL



9/28/17 – 9/30/17
Knoxville, TN


Wild on Wound Conference

10/4/17 - 10/7/17
Las Vegas, NV



10/20/17 - 10/22/17
Las Vegas, NV


» back to top


Press Releases


March 17, 2015
The National Necrotizing Fasciitis Foundation Names NovaBay's NeutroPhase as its Official "Flesh Eating Disease" Wound Cleanser


December 16, 2014
China Pioneer Pharma Joins Hand with NovaBay Pharmaceuticals and the NNFF To Offer Free New Life-Saving Treatment for “Flesh-Eating” Disease


November 4, 2014
NovaBay’s NeutroPhase Cleared for Sale by Taiwan FDA


October 27, 2014
NovaBay Pharmaceuticals Receives 2nd Major NeutroPhase Order for 150,000 Units from China Pioneer Pharma


September 25, 2014
NovaBay Receives First Large NeutroPhase Order From China Pioneer Pharma


September 3, 2014
China’s Food and Drug Administration has Cleared NovaBay’s NeutroPhase® Skin and Wound Cleanser for Sale throughout Mainland China by NovaBay’s Partner, China Pioneer Pharma


July 28, 2014
In RadioMD Interview, Dr. John Crew Describes Successful New Treatment for Flesh-Eating Disease


April 29, 2014

Chronic Wounds Cost The Nation More Than $25 Billion Per Year, Reports Ron Najafi, CEO of NovaBay Pharmaceuticals


April 24, 2014

NovaBay Pharmaceuticals’ NeutroPhase is Focus of Dr. John Crew’s Presentation at Advanced Wound Care Care Symposium


April 17, 2014

Wound Source Reports on the Role of NovaBay’s NeutroPhase® in Treatment of ‘Flesh Eating’ Bacteria


March 28, 2014

Triple Amputation From Flesh-Eating Disease in the United Kingdom Highlights Importance of NovaBay’s NeutroPhase Wound Cleanser


February 26, 2014

NovaBay Pharmaceuticals Grants Principle Business Enterprises Exclusive Marketing and Distribution Rights in the US for NeutroPhase® Skin and Wound Cleanser

February 17, 2014

NovaBay’s NeutroPhase Is Best In Class In Laboratory Study of 19 Top Commercial Wound Cleansers

February 7, 2014

NovaBay Pharmaceuticals to Present at the 34th Annual Dialysis Convention in Atlanta


February 6, 2014

Dr. John Crew Gives Grand Rounds Presentation on Treating Wounds with NovaBay’s NeutroPhase at Eisenhower Medical Center

January 28, 2014

Research Breakthrough For Deadly Flesh-Eating Disease Reported in the Journal Cell Highlights Importance of Neutralization of Toxins Associated with Flesh Eating Bacteria

December 11, 2013

NovaBay Pharmaceuticals Gain ISO 13485 Certification For The Design and Manufacturing of NeutroPhase®

November 19, 2013

NovaBay Pharmaceuticals Announces Publication of Novel Surgical Procedure for Life Threatening Wounds and Flesh Eating Bacteria


» back to top